Skip to main content
Caplight Logo









ZielBio

ZielBio

Private
Charlottesville, VirginiaHealthcare & Life Scienceshttps://zielbio.com

Last Round

VC Round

Nov 1, 2022

Total Funding Raised

$40.96M

Company Overview

ZielBio is a clinical-stage biotechnology company that identifies novel disease targets and develops therapeutic interventions to improve patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverymonoclonal antibodyoncologysolid tumorstherapeutic developmentcancer therapeuticsbiotech startupclinical-stage biotechtarget discoveryantibody therapydrug pipelinebiopharmacancer research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZielBio Comparables

Compare ZielBio with similar companies based on industry and business-model similarity.

ZielBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GV20 Therapeutics
84%
Tizona Therapeutics
82%
Hummingbird Bioscience
81%

ZielBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 1, 2022
Series BJul 1, 2022
Series ASep 26, 2019
SeedJun 16, 2017
SeedMay 17, 2011

ZielBio Investors

Notable investors and investment history

ZielBio investors
InvestorRounds
Mass General Brigham InnovationSeries A
Morningside VenturesSeries A
Morningside GroupSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2022

    $15M round completed.

  • Sep 26, 2019

    $25M round led by Mass General Brigham and Morningside.

ZielBio Filings

Explore SEC and related filing metadata, where available.

ZielBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ZielBio's valuation, stock price, and market status.

Is ZielBio a public or private company?

ZielBio is a private company.

What is the current stock price of ZielBio?

ZielBio is a private company with no public stock price. No recent secondary market data is available.

How much is ZielBio worth (valuation)?

Valuation information for ZielBio is not publicly available.

Can I buy ZielBio stock?

ZielBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ZielBio's last funding round?

ZielBio's most recent funding round was VC Round on November 1, 2022.

Who are the main investors in ZielBio?

Key investors in ZielBio include Mass General Brigham Innovation, Morningside Ventures.

Will ZielBio IPO soon?

No public IPO plans have been announced for ZielBio.

How can I track ZielBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ZielBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCharlottesville, Virginia
Year Founded2010
Last FundingNov 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?